Q1 EPS Estimates for Henry Schein Decreased by Analyst

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Research analysts at Barrington Research lowered their Q1 2025 earnings per share (EPS) estimates for Henry Schein in a research report issued to clients and investors on Thursday, January 30th. Barrington Research analyst M. Petusky now anticipates that the company will earn $1.06 per share for the quarter, down from their prior forecast of $1.12. Barrington Research currently has a "Outperform" rating and a $90.00 price objective on the stock. The consensus estimate for Henry Schein's current full-year earnings is $4.76 per share. Barrington Research also issued estimates for Henry Schein's Q2 2025 earnings at $1.20 EPS, Q3 2025 earnings at $1.22 EPS, Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $4.85 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.32 earnings per share.

A number of other equities research analysts have also issued reports on HSIC. Mizuho began coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price objective for the company. Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and upped their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Finally, Evercore ISI upped their price target on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. Seven analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $80.10.

Henry Schein Trading Up 0.9 %

NASDAQ:HSIC traded up $0.69 during trading hours on Friday, hitting $80.26. The company had a trading volume of 691,894 shares, compared to its average volume of 1,415,574. Henry Schein has a 1 year low of $63.67 and a 1 year high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average of $73.47 and a 200 day moving average of $71.52. The company has a market cap of $10.01 billion, a P/E ratio of 32.98, a P/E/G ratio of 2.21 and a beta of 0.91.

Insider Activity at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.14% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Henry Schein

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Clarkston Capital Partners LLC raised its holdings in Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock valued at $101,900,000 after acquiring an additional 71,560 shares in the last quarter. Nuance Investments LLC raised its holdings in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after purchasing an additional 414,748 shares in the last quarter. SG Americas Securities LLC raised its holdings in shares of Henry Schein by 1,622.3% in the 3rd quarter. SG Americas Securities LLC now owns 458,828 shares of the company's stock valued at $33,449,000 after purchasing an additional 432,187 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Henry Schein during the 3rd quarter worth $515,000. Finally, Olstein Capital Management L.P. increased its holdings in Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after buying an additional 16,000 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.